Stress-related cardiomyopathy syndromes

Circulation

Volumn 118, Issue 4, 2008, Pages 397-409

  Bybee, Kevin A ^a,c   Prasad, Abhiram ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b MAYO CLINIC   (United States)

^c Cardiovascular Consultants PA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; ADRENALIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMPHETAMINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ASMULOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE DERIVATIVE; COCAINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUORODEOXYGLUCOSE F 18; HEPARIN; METHYLXANTHINE DERIVATIVE; TROPONIN I; UNCLASSIFIED DRUG; WARFARIN; CATECHOLAMINE;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DISEASE COURSE; ELECTROCARDIOGRAM; EMBOLISM; EMOTIONAL STRESS; HEAD INJURY; HEART CATHETERIZATION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE WALL; HEART MOVEMENT; HEART MUSCLE ISCHEMIA; HEART VENTRICLE THROMBOSIS; HUMAN; HYPOTENSION; NEUROGENIC STRESS CARDIOMYOPATHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHEOCHROMOCYTOMA; PHYSICAL STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; QT PROLONGATION; RECURRENT DISEASE; REVIEW; RISK; SEPSIS; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; SUBARACHNOID HEMORRHAGE; SURGICAL TECHNIQUE; T WAVE INVERSION; TAKOTSUBO CARDIOMYOPATHY; TELEMETRY; THORAX PAIN; CARDIOMYOPATHY; DRUG EFFECT; HEART; HEART LEFT VENTRICLE FUNCTION; PHYSIOLOGY; STRESS;

CARDIOMYOPATHIES; CATECHOLAMINES; HEART; HUMANS; STRESS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 49149117271     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.677625     Document Type: Review

References (94)

1. Samuels MA. The brain-heart connection. Circulation. 2007;116:77-84.
2. Tsuchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, Yoshiyama M, Miyazaki S, Haze K, Ogawa H, Honda T, Hase M, Kai R, Morii I, for the Angina Pectoris-Myocardial Infarction Investigations in
3. dysfunction with ST segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J. 2002;143: 448-455.
4. Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol. 2003;41:737-742.
5. Seth PS, Aurigemma GP, Krasnow JM, Tighe DA, Untereker WJ, Meyer TE. A syndrome of transient left ventricular apical wall motion abnormality in the absence of coronary disease: a perspective from the United States. Cardiology. 2003;100:61-66.
6. Kurowski V, Kaiser A, von Hof K, Killermann DP, Mayer B, Hartmann F, Schunkert H, Radke PW. Apical and mid-ventricular transient left ventricular dysfunction syndrome (Tako-tsubo cardio- myopathy): frequency, mechanisms, and prognosis. Chest. 2007;132: 809-816.
7. Desmet WJ, Adriaenssens BJ, Dens JA. Apical ballooning of the left ventricle: first series in white patients. Heart. 2003;89:1027-1031.
8. Sharkey SW, Shear W, Hodges M, Herzog CA. Reversible myocardial contraction abnormalities in patients with an acute noncardiac illness. hest. 1998;114:98-105.
9. Sharkey SW, Lesser JR, Andrey G, Zenovich AG, Maron MS, Lindberg J, Longe TF, Maron BJ. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005;111:472-479.
10. Kawai S, Suzuki H, Yamaguchi H, Tanaka K, Sawada H, Aizawa T, Watanabe M, Tamura T, Umawatari K, Kawata M, Nakamura T, Yamanaka O, Okada R. Ampulla cardiomyopathy "Takotsubo" cardio- myopathy: reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J. 2000;64:156-159.
11. Akashi YJ, Nakazawa K, Sakakibara M, Miyake F, Koike H, Sasaka K. The clinical features of Takotsubo cardiomyopathy. QJM. 2003;96:563-573.
12. Wittstein IS, Thiemann DR, Lima JAC, Baughman KL, Shulman SP,Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC. Neuro- humoral features of myocardial stunning due to sudden emotional stress. Engl J Med. 2005;352:539-548.
13. Pavin D, Le Breton H, Daubert C. Human stress cardiomyopathy mimicking acute myocardial syndrome. Heart. 1997;78:509-511.
14. Dote K, Sato H, Uchinda AT, Ishihara M. Myocardial stunning due to simultaneous multivessel spasms: a review of 5 cases. J Cardiol. 1991;21:203-214.
15. Maron BJ, Towbin JA, Thiene G, Antzelvich C, Corrado D, Arnett D,Moss AJ, Seidman CE, Young JB. American Heart Association contemporary definitions and classification of the cardiomyopathies: American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807-1816.
16. Ako J, Sudhir K, Farouque HMO, Honda Y, Fitzgerald PJ. Transient left ventricular dysfunction under severe stress: brain-heart relationship revisited. Am J Med. 2006;119:10-17.
17. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or Takotsubo cardiomyopathy: a systematic review. Eur Heart J. 2006;27:1523-1529.
18. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DEJr, ChaveyWEII, FesmireFM, HochmanJS, LevinTN, LincoffAM,Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol. 2007;50:e1-e157.
19. Watanabe H, Kodama M, Okura Y, Aizawa Y, Tanabe N, Chinushi M, Nakamura Y, Nagai T, Sato M, Okabe M. Impact of earthquakes on Takotsubo cardiomyopathy. JAMA. 2005;294:305-307.
20. Bybee KA, Motiei A, Syed I, Kara T, Lennon R, Murphy J, Wright RS, Rihal C. Electrocardiography cannot reliably differentiate
21. transient left ventricular apical ballooning syndrome from anterior ST- segment elevation myocardial infarction. J Electrocardiol. 2007;40:38.e1-e6.
22. Ogura R, Hiasa Y, Takahashi T, Yamaguchi K, Fujiwara K, Ohara Y, Nada T, Ogata T, Kusunoki K, Yuba K, Hosokawa S, Kishi K, Ohtani R. Specific findings of the standard 12-lead ECG in patients with Takotsubo cardiomyopathy: comparison with the findings of acute anterior myocardial infarction. Circ J. 2003;67:687-690.
23. Kume T, Akasaka T, Kawamoto T, Watanabe N, Yoshitani H, Akiyama M, Koyama Y, Neishi Y, Tsukiji M, Yoshida K. Relationship between coronary flow reserve and recovery of regional left ventricular dysfunction in patients with tako-tsubo-like transient left ventricular dysfunction. J Cardiol. 2004;43:123-129.
24. Elesber A, Lerman A, Bybee KA, Murphy JG, Barsness G, Singh M, Rihal CS, Prasad A. Myocardial perfusion in apical ballooning syndrome: correlates of myocardial injury. Am Heart J. 2006;152:469.e9-e13.
25. Parodi G, Del Pace S, Salvadori C, Carrabba N, Olivotto I, Gensini GF. Tuscany registry of Tako-Tsubo cardiomyopathy: left ventricular apical ballooning syndrome as a novel cause of acute mitral regurgitation. JAm Coll Cardiol. 2007;50:647-649.
26. Prasad A. Apical ballooning syndrome: an important differential diagnosis of acute myocardial infarction. Circulation. 2007;115:e56-e59.
27. Hurst RT, Askew JW, Reuss CS, Lee RW, Sweeney JP, Fortuin FD, Oh JK, Tajik AJ. Transient midventricular ballooning: a new variant. JAm Coll Cardiol. 2006;48:579-583.
28. Reuss CS, Lester SJ, Hurst RT, Askew JW, Nager P, Lusk J, Altemose GT, Tajik AJ. Isolated left ventricular basal ballooning phenotype of transient cardiomyopathy in young women. Am J Cardiol. 2007;99:1451-1453.
29. Shimizu M, Kato Y, Masai H, Shima T, Miwa Y. Recurrent episodes of Takotsubo-like transient apical ballooning occurring in different regions: a case report. J Cardiol. 2006;48:101-107.
30. Elian D, Osherou A, Matetzky S, Hod H, Guetta V, Feinberg MS, Di Segni E. Left ventricular apical ballooning syndrome: not an uncommon variant of acute myocardial infarction in women. Clin Cardiol. 2006;29:9-12.
31. Donahue D, Movahed MR. Clinical characteristics, demographics and prognosis of transient left ventricular apical ballooning syndrome. Heart Fail Rev. 2005;10:311-316.
32. ElesberA, Bybee KA, Prasad A, WrightRS, Lerman A, Rihal CS. Right ventricular dysfunction in the transient apical ballooning syndrome: incidence and impact on clinical outcome. J Am Coll Cardiol. 2006;47: 1082-1083.
33. Haghi D, Athanasiadis A, Papavassiliu T, Suselback T, Fluecter S, Mahrholdt H, Borggrefe M, Sechtem U. Right ventricular involvement in Takotsubo cardiomyopathy. Eur Heart J. 2006;27:2433-2439.
34. Ueyama T, Hano T, Kasamatsu K, Yamamoto K, Tsuruo Y, Nishio I. Emotional stress induces transient left ventricular hypokinesis in the rat via activation of the cardiac adrenoceptors: a possible animal model of "tako-tsubo" cardiomyopathy. Circ J. 2002;66:712-713.
35. Elesber A, Prasad A, Lennon R, Lerman A Rihal CS. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007;50:448-452.
36. Ibanez B, Navarro F, Cordoba M, M-Alberca P, Farre J. Tako-tsubo transient left ventricular apical ballooning: is intravascular ultrasound the key to resolve the enigma? Heart. 2005;91:102-104.
37. Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, Umemura T, Nakamura S, Yoshida M, Sato H. Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction. J Am Coll Cardiol. 2003;41:743-748.
38. Ito K, Sugihara H, Katoh S, Azuma A, Nakagawa M. Assessment of Takotsubo (ampulla) cardiomyopathy using 99mTC-tetrofosmin myo- cardial SPECT: comparison with acute coronary syndrome. Ann Nucl Med. 2003;17:115-122.
39. Bybee KA, Murphy J, Wright RS, Prasad A, Rihal CS, Chareonthaitawee P. Acute impairment of regional myocardial glucose utilization in the apical ballooning (Takotsubo) syndrome. J Nuc Cardiol. 2006;13:244-250.
40. McNulty PH, Jagasia D, Cline GW, Ng CK, Whiting JM, Garg P,Shulman GI, Soufer R. Persistent changes in myocardial glucose metabolism in vivo during reperfusion of a limited-duration coronary occlusion. Circulation. 2000;101:917-922.
41. Hashimoto K, Uehara T, Ishida Y, Nongi H, Kusuoka H, Nishimura T. Paradoxical uptake of F-18 fluorodeoxyglucose during the sub-acute phase in patients with acute myocardial infarction. Ann Nucl Med. 1996; 10:93-98.
42. DiCarli MF, Prcevski P, Singh TP, Janisse J, Ager J, Muzik O, Vander Heide R. Myocardial blood flow, function, and metabolism in repetitive stunning. J Nucl Med. 2000;41:1227-1234.
43. Schelbert HR, Buxton D. Insights into coronary artery disease gained from metabolic imaging. Circulation. 1988;78:496-505.
44. Schelbert HR, Henze E, Phelps ME, Kuhl DE. Assessment of regional myocardial ischemia by positron-emission computed tomography. Am Heart J. 1982;103:588-597.
45. Nef HM, Mollman H, Kostin S, Troidl C, Voss S, Weber M, Dill T, Rolf A, Brandt R, Hamm CW, Elsasser A. Tako-tsubo cardiomyopathy: inter- individual structural analysis in the acute phase and after functional recovery. Eur Heart J. 2007;28:2456-2464.
46. Kneale BJ, Chowienczyk PJ, Brett SE, Coltart DJ, Ritter JM. Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol. 2000;36:1233-1238.
47. Mori H, Ishikawa S, Kojima S, Hayashi J, Wananabe Y, Hoffman JI, Okino H. Increased responsiveness of left ventricular apical myocardium to adrenergic stimuli. Cardiovasc Res. 1993;27:192-198.
48. Mayer SA, Lin J, Homma S, Solomon RA, Lennihan L, Sherman D, Fink ME, Beckford A, Klebanoff LM. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke. 1999;30:780-786.
49. Tung PP, Olmsted E, Kopelnik A, Banki NM, Drew BJ, Ko N, Lawton MT, Smith W, Foster E, Young WL, Zaroff JG. Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke. 2005;36:1567-1571.
50. Banki NM, Kopelnik A, Dae MW, Miss J, Tung P, Lawton MT, Drew BJ,Foster E, Smith W, Parmley WW, Zaroff JG. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation. 2005;112:3314-3319.
51. Tung P, Kopelnik A, Banki N, Ong K, Ko N, Lawton MT, Gress D,Drew B, Foster E, Parmley W, Zaroff J. Predictors of neurocar- diogenic injury after subarachnoid hemorrhage. Stroke. 2004;35:548-553.
52. Parekh N, Venkatesh B, Cross D, Leditschke A, Atherton J, Miles W, Winning A, Clague A, Rickard C. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol.2000;36:1328 -1335.
53. Kono T, Morita H, Kuroiwa T, Onaka H, Takatsuka H, Fujiwara A. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol. 1994;24:636-640.
54. Kuroiwa T, Morita H, Tanabe H, Ohta T. Significance of ST-segment elevation in electrocardiogram in patients with ruptured cerebral aneu-rysms. Acta Neurochir (Wien). 1995;133:141-146.
55. Dujardin KS, McCully RB, Wijdicks EFM, Tazelaar HD Seward JB,McGregor CGA, Olson LJ. Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. J Heart Lung Transplant. 2001;20:350-357.
56. Banki N, Kopelnik A, Tung P, Lawton MT, Gress D, Drew B, Dae M,Foster E, Parmley W, Zaroff J. Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic dysfunction in patients with subarachnoid hemorrhage. J Neurosurg.2006;105:15-20.
57. Zaroff JG, Rordorf GA, Ogilvy CS, Picard MH. Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr. 2000;13:774-779.
58. Lee VH, Oh JK, Mulvagh SL, Wijdicks EFM. Mechanisms in neu- rogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5:243-249.
59. Khechinashvili G, Asplund K. Electrocardiographic changes in patients with acute stroke: a systematic review. Cerebrovasc Dis. 2002;14:65-66.
60. Lanzino G, Kongable GL, Kassell NF. Electrocardiographic abnormalities after nontraumatic subarachnoid hemorrhage. J Neurosurg Anesthesiol. 1994;6:156 -162.
61. Lee VH, Connolly HM, Fulgham JR, Manno EM, Brown RD, Wijdicks F. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg. 2006;105:264-270.
62. Bulsara KR, McGirt MJ, Liao L, Villavicencio AT, Borel C, Alexander MJ, Friedman AH. Use of the peak troponin value to differentiate myo- cardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg.2003;98:524-528.
63. Zaroff JG, Rordorf GA, Titus JS, Newell JB, Nowak NJ, Torchiana DF,Aretz T, Picard MH. Regional myocardial perfusion after experimental subarachnoid hemorrhage. Stroke. 2000;31:1136-1143.
64. Cechetto DF, Hachinski V. Cardiovascular consequences of experimental stroke. In: Cechetto DF, achinski V, eds. Bailliere's Clinical Neurology, Neurocardiology. Vol 6. London, UK: WB Saunders; 1997:297-308.
65. Samuals MA. Neurogenic heart disease: a unifying hypothesis.Am J Cardiol. 1987;60:15J-19J.
66. Masuda T, Sato K, Yamamota S, Matsuyama N, Shimohama T, Mat- sunaga A, Obuchi S, Shiba Y, Shimizu S, Izumi T. Sympathetic nervous activity and myocardial damage immediately after subarach- noid hemorrhage in a unique animal model. Stroke. 2002;33:1671-1676.
67. Benedict CR, Loach AB. Clinical significance of plasma adrenaline and noradrenaline concentrations in patients with subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry. 1978;41:113-117.
68. Elrifai AM, Bailes JE, Shih S-R, Diazumba S, Brillman J. Characterization of the cardiac effects of acute subarachnoid hemorrhage in dogs.Stroke. 1996;27:737-742.
69. Neil-Dwyer G, Walter P, Cruickshank JM, Doshi B, O'Gorman P. Effect of propranolol and phentolamine on myocardial necrosis after subarach-noid haemorrhage. BMJ. 1978;2:990-992.
70. Cruickshank JM, Neil-Dwyer G, Degaute JP, Hayes Y, Kuurne T, Kytta J, Vincent JL, Carruthers ME, Patel S. Reduction of stress/catecholamine- induced cardiac necrosis by beta 1-selective blockade. Lancet. 1987;2:585-589.
71. Jensen JK, Christensen SR, Bak S, Atar D, Hoilund-Carlson PE, Mickley H. Frequency and significance of troponin T elevation in acute ischemic troke. Am J Cardiol. 2007;99:108-112.
72. Sharkey SW, Shear W, Hodges M, Herzog CA. Reversible myocardial contraction abnormalities in patients with acute noncardiac illness. Chest.1998;114:98-105.
73. Quenot J-P, Le Teuff G, Quantin C, Doise J-M, Abrahamowicz M, Masson D, Blettery B. Myocardial injury in critically ill patients. Chest.2005;128: 2758-2764.
74. Maeder M, Fehr T, Rickli H, Ammann P. Sepsis-associated myocardial ysfunction. Chest. 2006;129:1349-1366.
75. Court O, Kumar A, Parrillo JE, Kumar A. Clinical review: myocardial depression in sepsis and septic shock. Crit Care. 2002;6:500-508.
76. Park J-H, Kang S-J, Song J-K, Kim HK, Lim CM, Kang D-H, Koh Y.Left ventricular apical ballooning due to severe physical stress in patients dmitted to the medical ICU. Chest. 2005;128:296-302.
77. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE. Profound but reversible myo- cardial depression in patients with septic shock. Ann Intern Med. 1984;100:483-490.
78. Krishnagopalan S, Kumar A, Parrillo JE, Kumar A. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care. 2002;8:376-388.
79. ver Elst KM, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK. Cardiac troponin I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem. 2000;46:650-657.
80. Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E, Minder EI, Rickli H, Fehr T. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. JAmColl Cardiol. 2003;41:2004-2009.
81. Hoesel LM, Niederbichler AD, Ward PA. Complement-related molecular events in sepsis leading to heart failure. Mol Immunol. 2007;44:95-102.
82. Cunnion RE, Schaer GL, Parker MM, Natanson C, Parrillo JE. The coronary circulation in human septic shock. Circulation. 1986;73:637-644.
83. Ruiz Bailen M, Aguayo de Hoyos E, Lopez Martnez A, Daz Castellanos MA, Ruiz Navarro S, Fierro Roson LJ, Gomez Jimenez FJ, Issa-Massad Khozouz Z. Reversible myocardial dysfunction, a possible complication in critically ill patients without heart disease. J Crit Care. 2003;18:245-252.
84. Sardesai SH, Mourant AJ, Sivathandon Y, Farrow R, Gibbons DO. Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J. 1990;63:234-237.
85. Wood R, Commerford PJ, Rose AG, Tooke A. Reversible catecholamine- induced cardiomyopathy. Am Heart J. 1991;121:610-613.
86. Frustaci A, Loperfido F, Gentiloni N, Caldarulo M, Morgante E, Russo MA. Catecholamine-induced cardiomyopathy in multiple endocrine neo-plasia. Chest. 1991;99:382-385.
87. Shub C, Cueto-Garcia L, Sheps SG, Ilstrup DM, Tajik AJ. Echocar- diographic findings in pheochromocytoma. Am J Cardiol. 1986;57:971-975.
88. Meune C, Bertherat J, Dousset B, Jude N, Bertagna X, Duboc D, Weber S. Reduced myocardial contractility assessed by tissue Doppler echocar- diography is associated with increased risk during adrenal surgery of patients with pheochromocytoma: report of a preliminary study. JAmSocEchocardiogr. 2006;19:1466-1470.
89. Yoshinaga K, Torii H, Tahara M. A serial echocardiographic observation of acute heart injury associated with pheochromocytoma crisis. IntJ Cardiol. 1998;66:199-202.
90. Takizawa M, Kobayakawa N, Uozumi H, Yonemura S, Kodama T, Fukusima K, Takeuchi H, Kaneko Y, Kaneko T, Fujita K, Honma Y, Aoyagi T. A case of transient left ventricular ballooning with pheochro- mocytoma, supporting pathogenetic role of catecholamines in stressinduced cardiomyopathy or Takotsubo cardiomyopathy. Int J Cardiol.2007;114:e15-17.
91. Raper R, Fisher M, Bihari D. Profound, reversible, myocardial depression in acute asthma treated with high-dose catecholamines. Crit Care Med.1992;20:710 -712.
92. Akashi YJ, Nakazawa K, Sakakibara M, Miyaki F, Sasaka K. Reversible left ventricular dysfunction "takotsubo" cardiomyopathy related to catecholamine cardiotoxicity. J Electrocardiol. 2002;35:351-356.
93. Bertolet BD, Freund G, Martin CA, Perchalski DL, Williams CM,Pepine CJ. Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population. Clin Cardiol. 1990;13:323-328.
94. Pitts WR, Vongpatanasin W, Cigarroa JE, Hillis LD, Lange RA. Effects of intracoronary infusion of cocaine on left ventricular systolic and diastolic function in humans. Circulation. 1998;97:1270-1273.